Connectus Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Connectus Wealth’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$3.55M	Buy	25,889 +105	+0.4%	+$14.3K	0.1%	139
2023 Q4	$3.5M	Sell	25,784 -4,158	-14%	-$507K	0.07%	195
2023 Q3	$3.66M	Buy	29,942 +1,561	+6%	+$199K	0.08%	195
2023 Q2	$3.6M	Buy	28,381 +751	+3%	+$97.6K	0.08%	166
2023 Q1	$3.57M	Sell	27,630 -370	-1%	-$48.4K	0.09%	170
2022 Q4	$3.68M	Sell	28,000 -1,415	-5%	-$183K	0.09%	158
2022 Q3	$3.44M	Buy	29,415 +1,856	+7%	+$230K	0.07%	210
2022 Q2	$3.24M	Buy	+27,559	New	+$3.27M	0.07%	170

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Connectus Wealth's IBB Position: Q1 2024 in Review

Connectus Wealth increased its iShares Biotechnology ETF (IBB) stake by 0.41% in Q1 2024, buying an estimated $14.3K and bringing the position to 25,889 shares worth $3.55M. The position accounts for 0.1% of the portfolio, ranked #139.

Connectus Wealth first reported a position in IBB in Q2 2022 and has held it in 8 quarters since. The position peaked at $3.68M in Q4 2022. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

Connectus Wealth held 25,889 shares of iShares Biotechnology ETF worth $3.55M as of Q1 2024.
Connectus Wealth bought 105 iShares Biotechnology ETF shares in Q1 2024, an estimated $14.3K.
iShares Biotechnology ETF made up 0.1% of Connectus Wealth's portfolio in Q1 2024, its #139 holding.
Connectus Wealth first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 8 quarters since.
Connectus Wealth's iShares Biotechnology ETF position peaked at $3.68M in Q4 2022.
899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.